Three major US synthetic biology companies - Antheia, Genomatica and Ginkgo Bioworks – have launched the Synthetic Biology (SynBio) Coalition. Its stated aim is to promote investment in and support for the industry in the US, in partnership with the federal government.

“The coalition believes that continued investment in synthetic biology, research infrastructure and manufacturing capacity is critical to realising the full potential of this industry and maintaining American global leadership,” the firms stated.